ScholarLens Back to search
2020•Polskie Archiwum Medycyny WewnętrznejOpen access

Comparison of 12-month kinetics of serum markers of fibrosis between treatment with angiotensin receptor neprilysin inhibitor (ARNI) and angiotensin converting enzyme inhibitor (ACE-I) in patients with heart failure with reduced ejection fraction

Sylwia Wiśniowska‐Śmiałek, Ewa M. Dziewięcka, Katarzyna Holcman, Piotr Stanisław Podolec, Ewa Wypasek, Paweł Rubiś

Open full text 0 citations

Abstract

DOI: 10.20452/pamw.15599, Published online: September 15, 2020, Authors: Sylwia Wiśniowska-Śmiałek1, Ewa Dziewięcka1, Katarzyna Holcman1, Piotr Podolec1, Ewa Wypasek2,3, Paweł Rubiś1

Open-access reader

About this research paper

What this paper is about

DOI: 10.20452/pamw.15599, Published online: September 15, 2020, Authors: Sylwia Wiśniowska-Śmiałek1, Ewa Dziewięcka1, Katarzyna Holcman1, Piotr Podolec1, Ewa Wypasek2,3, Paweł Rubiś1

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

DOI: 10.20452/pamw.15599, Published online: September 15, 2020, Authors: Sylwia Wiśniowska-Śmiałek1, Ewa Dziewięcka1, Katarzyna Holcman1, Piotr Podolec1, Ewa Wypasek2,3, Paweł Rubiś1

Key concepts: Neprilysin, ACE inhibitor, Heart failure, Angiotensin-converting enzyme, Internal medicine, Medicine, Endocrinology, Fibrosis

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Comparison of 12-month kinetics of serum markers of fibrosis between treatment with angiotensin receptor neprilysin inhibitor (ARNI) and angiotensin converting enzyme inhibitor (ACE-I) in patients with heart failure with reduced ejection fraction — Research Paper | ScholarLens